NMN is a precursor to NAD+. NAD+ is crucial for energy production, DNA repair, and regulating various cellular processes.
Uthever® NMN, the world's first clinically-proven NMN brand, has released a new NMN whitepaper, providing industry insights, the latest scientific findings on NMN, and comprehensive global regulatory information.
As the leading NMN brand, Uthever® has built a global network spanning over 50 countries, offering health solutions to millions of consumers. Uthever® NMN has applied for EU Novel Food status, with an estimated approval expected by the end of 2024.
